Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Photodiagnosis and Photodynamic Therapy|June 16, 2015
Effects of varying local temperature on the optical properties of cells in-vitroIftikhar Ahmad, Abdul Rehman, Junaid A Khan, et al.
JRSM Cardiovascular Disease|May 19, 2025
Higher cortisol level and reduced circulating triiodothyronine in patients with cardiovascular diseases: A case-control studyMuhammad Javid, Safir Ullah Khan, Maleeha Akram, et al.
Frontiers in Molecular Biosciences|January 26, 2024
Classification of clinically actionable genetic mutations in cancer patientsMuhammad Shahzad, Muhammad Rafi, Wadee Alhalabi, et al.
Dose-Response : a Publication of International Hormesis Society|May 5, 2020
Dose-Dependent Internalization and Externalization Integrity Study of Newly Synthesized 99mTc-Thymoquinone Radiopharmaceutical as Cancer Theranostic AgentSaima Tariq, Syed Ali Raza Naqvi, Sumaira Naz, et al.
Sensors (Basel, Switzerland)|April 12, 2022
Millimeter-Wave Smart Antenna Solutions for URLLC in Industry 4.0 and BeyondAbdul Jabbar, Qammer H Abbasi, Nadeem Anjum, et al.
Microbial Pathogenesis|November 3, 2018
A comprehensive review on past, present and future aspects of canine theileriosisHammad Nayyar Ghauri, Muhammad Ijaz, Shahid Hussain Farooqi, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Effect of smoking on drug-resistant tuberculosis treatment outcomes and exploring potential pathways: A multicountry cohort studyMatthew L Romo, Allison LaHood, Helen R Stagg, et al.
BMJ Open Respiratory Research|December 25, 2025
Effect of smoking on drug-resistant tuberculosis treatment outcomes and potential mechanistic pathways: a multicountry cohort studyMatthew L Romo, Allison LaHood, Helen R Stagg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2022
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line DrugsHelena Huerga, Uzma Khan, Mathieu Bastard, et al.
Pageof 5